Skip to main content
CDC Website

Report

Estimated HIV Incidence in the United States, 2006–2009

This report in the form of a journal article describes a study to estimate the size and direction of the HIV epidemic in the United States from 2006–2009. The report updated earlier estimates of HIV incidence for 2006 based on additional data and methodological refinements and extended previous results with estimates for 2007, 2008, and 2009.

MMWR: Hepatitis C Virus Infection Among Adolescents and Young Adults – Massachusetts, 2002-2009

This MMWR report describes results of the Massachusetts Department of Public Health surveillance initiative to collect detailed information on hepatitis C virus (HCV) cases reported during 2007-2009 among 15-24-year olds, and to examine the data for trends through 2009. The results reveal the continued increase in rates of newly reported HCV infection among this age group. Cases were reported from all areas of the state, occurred predominantly among non-Hispanic white persons, and were equally distributed among male and females.

MMWR: Potential Transmission of Viral Hepatitis Through Use of Stored Blood Vessels as Conduits in Organ Transplantation – Pennsylvania, 2009

This report summarizes results of an investigation in which HCV was transmitted when a transplant facility mistakenly used a blood vessel conduit from an HCV-seropositive donor in a seronegative recipient in May 2009. In November of 2009, a second transplant facility identified two cases of potential hepatitis transmission from vessel conduits.

MMWR: Deaths From Acute Hepatitis B Virus Infection Associated With Assisted Blood Glucose Monitoring in an Assisted-Living Facility – North Carolina, August-October 2010

This report discusses the investigation of a hepatitis B virus (HBV) outbreak in an assisted living facility. The outbreak occurred because of the staff’s use of unsafe practices, including sharing reusable fingerstick lancing devices approved for single patient use only, and shared use of blood glucose meters without cleaning and disinfection between patients.

Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex With Men – New York City, 2005-2010

This article reports on a matched case-control study and viral analysis that examined the role of sexual transmission of Hepatics C virus (HCV) among HIV-infected men who have sex with men. In all, 22 case-patients and 53 control subjects were enrolled in the study. Participants completed self-administered questionnaires regarding sexual practices and drug-use behaviors during the 12 months preceding diagnosis or preceding the questionnaire.

Evaluation of Large Jail STD Screening Programs, 2008-2009

This report examines existing sexually transmitted disease (STD) screening programs in large jails to learn lessons that can benefit other health departments that want to establish or expand chlamydia (CT) and gonorrhea (GC) screening programs in their local jails. It provides key findings and recommendations for implementing and/or expanding jail STD screening programs. The appendices give summaries of each jail vist and contact information is also provided from each jail visit.

Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates --- United States, 2000--2010

This report summarizes trends in cephalosporin susceptibility among N. gonorrhoeae isolates in the United States during 2000--2010 using data from the Gonococcal Isolate Surveillance Project (GISP). During that period, the percentage of isolates with elevated minimum inhibitory concentrations (MICs) to cephalosporins (=0.25 µg/mL for cefixime and =0.125 µg/mL for ceftriaxone) increased from 0.2% in 2000 to 1.4% in 2010 for cefixime and from 0.1% in 2000 to 0.3% in 2010 for ceftriaxone.

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series; males aged 22 through 26 years may be vaccinated. These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 through 26 years.

MMWR: HIV Infection — United States, 2005 and 2008

This report presents estimated numbers of HIV and AIDS diagnoses from the 42 areas (37 states and five US dependent areas) with confidential name-based HIV infection reporting since at least 2005. It also includes the statistics reported to CDC through 2008. The data presented in this report are subject to at least four limitations. First, HIV infection diagnoses might reflect both HIV incidence and testing patterns. Second, data were unavailable from certain states.

HIV/AIDS at 30: A Public Opinion Perspective

This report presents results of the Kaiser Family Foundation's 8th national survey on HIV/AIDS since 1995. The survey examined public opinion about HIV/AIDS and the national efforts to prevent and treat it. It examined broad national trends in public opinion on the past several decades and took an in-depth look at the views and experiences of black Americans and young adults under the age of 30 years who have never known a world without HIV. It also focused on trends in reported HIV testing rates and experiences.

Was this page helpful? Give Feedback